Lista de obras - A Chudecka-Głaz - Dominio Público Uruguay

A rare case of peritoneal disseminated angiosarcoma 20 years after ovarian cancer diagnosis

artículo científico publicado en 2013

Activin A levels in serum and cyst fluid in epithelial tumors of the ovary.

artículo científico publicado en 2005

Age at diagnosis and other prognosticators in epithelial ovarian cancers

artículo científico publicado en 2002

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.

artículo científico publicado en 2015

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

artículo científico publicado en 2012

BRCA1 mutation, leptin and estrogen levels in breast cancer patients

artículo científico publicado en 2005

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?

artículo científico publicado en 2016

Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries

artículo científico publicado en 2013

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

artículo científico publicado en 2018

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

artículo científico publicado en 2017

Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer

artículo científico publicado en 2018

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

artículo científico publicado en 2017

Concentrations of follicle stimulating hormone are increased in ovarian tumor fluid: implications for the management of ovarian cancer.

artículo científico publicado en 2008

Conservative treatment of a young patient with thyroid carcinoma in adult ovarian teratoma - case report.

artículo científico publicado en 2014

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

artículo científico publicado en 2018

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

artículo científico publicado en 2016

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

artículo científico publicado en 2017

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

scientific article published on 06 December 2019

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

artículo científico publicado en 2019

Ectopic pregnancy treatment by combination therapy.

artículo científico publicado en 2016

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.

artículo científico publicado en 2018

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

artículo científico publicado en 2003

Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors

artículo científico publicado en 2012

FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.

artículo científico publicado en 2004

Favorable effects of long-term therapy with gonadoliberin analogues in three patients with advanced and recurrent ovarian cancer

artículo científico publicado en 2009

GnRH analogues as an adjuvant therapy for ovarian cancer patients.

artículo científico publicado en 2003

Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.

artículo científico publicado en 2003

Granulosa cell tumor in different periods of women's life

artículo científico publicado en 2003

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

artículo científico publicado en 2017

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

artículo científico publicado en 2014

Human epididymal protein 4 (HE4) is a novel biomarker and a promising prognostic factor in ovarian cancer patients

artículo científico publicado en 2012

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department - the follow-up at 1 year

artículo científico publicado en 2017

Inhibin A levels in cyst fluid from epithelial ovarian tumors

artículo científico publicado en 2004

Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer

artículo científico publicado en 2006

MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors

artículo científico publicado en 2016

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

artículo científico publicado en 2018

New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation.

artículo científico publicado en 2016

Operative treatment of developmental abnormalities of sexual organs in girls

artículo científico publicado en 1999

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

artículo científico publicado en 2003

Parovarian cysts--not always benign

artículo científico publicado el 1 de noviembre de 2002

Premature menopause in patients with BRCA1 gene mutation

artículo científico publicado en 2006

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.

artículo científico publicado en 2016

ROMA, an algorithm for ovarian cancer.

artículo científico publicado en 2014

Risk Model in Women with Ovarian Cancer Without Mutations

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

artículo científico publicado en 2014

Serum YKL-40 levels in patients with ovarian cancer and women with BRCA1 gene mutation--comparison to CA 125 antigen

artículo científico publicado en 2009

Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women

scientific article published on 01 January 2008

Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis - A multicentre study

scientific article published on 26 February 2019

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.

artículo científico publicado en 2018

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients

artículo científico publicado en 2020

The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania

artículo científico publicado en 2016

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

artículo científico publicado en 2017

Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

artículo científico publicado en 2004

[Adolescent endometriosis]

scientific article published on 01 May 2001

[Behavior of SCC antigen in girls with a high risk of developing cervical carcinoma]

scientific article published on 01 June 1993

[Effectiveness of combined treatment in patient with advanced ovarian carcinoma]

artículo científico publicado en 2002

[Giant benign ovarian tumor coexisting with late pregnancy--a case report]

scientific article published on 01 June 2008

[Laparoscopy in the diagnosis and treatment of pathology of sexual organs in girls]

artículo científico publicado en 1999

[Surgical treatment in child gynecology. Germ cell tumors of the ovary in girls]

artículo científico publicado en 1999

[The comparison of CA-125 and CEA levels in serum and ovarian cyst fluid in girls and young women]

artículo científico publicado en 1999

[The levels of selected hormones in serum and ovarian cyst fluid in girls and young women]

artículo científico publicado en 1999

sFlt-1/PlGF and Doppler ultrasound parameters in SGA pregnancies with confirmed neonatal birth weight below 10th percentile

artículo científico publicado en 2018

Lista de obras de A Chudecka-Głaz

A rare case of peritoneal disseminated angiosarcoma 20 years after ovarian cancer diagnosis

Activin A levels in serum and cyst fluid in epithelial tumors of the ovary.

Age at diagnosis and other prognosticators in epithelial ovarian cancers

Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.

Association of common WRAP 53 variant with ovarian cancer risk in the Polish population

BRCA1 mutation, leptin and estrogen levels in breast cancer patients

Can ROMA algorithm stratify ovarian tumor patients better when being based on specific age ranges instead of the premenopausal and postmenopausal status?

Characteristics of selected clinical features in BRCA1 mutation carriers affected with breast cancer undergoing preventive female genital tract surgeries

Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.

Clinical Relevance of NGAL/MMP-9 Pathway in Patients with Endometrial Cancer

Clinical efficacy of p16/Ki-67 dual-stained cervical cytology in secondary prevention of cervical cancer

Clinical importance of serum HE4 and MMP2 levels in endometrial cancer patients

Concentrations of follicle stimulating hormone are increased in ovarian tumor fluid: implications for the management of ovarian cancer.

Conservative treatment of a young patient with thyroid carcinoma in adult ovarian teratoma - case report.

Could HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?

Diagnostic usefulness of the Risk of Ovarian Malignancy Algorithm using the electrochemiluminescence immunoassay for HE4 and the chemiluminescence microparticle immunoassay for CA125.

Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

Double-Emulsion Copolyester Microcapsules for Sustained Intraperitoneal Release of Carboplatin

Ectopic pregnancy treatment by combination therapy.

Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.

Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen

Evaluation of serum levels of sCD30L ligand in patients with ovarian cancer in terms of selected clinico-pathological factors

FSH and LH serum/tumor fluid ratios and malignant tumors of the ovary.

Favorable effects of long-term therapy with gonadoliberin analogues in three patients with advanced and recurrent ovarian cancer

GnRH analogues as an adjuvant therapy for ovarian cancer patients.

Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.

Granulosa cell tumor in different periods of women's life

HE4 Serum Levels in Patients with BRCA1 Gene Mutation Undergoing Prophylactic Surgery as well as in Other Benign and Malignant Gynecological Diseases

HE4 tumor marker concentration in neoplastic peritoneal effusion and in peritoneal fluid associated with benign gynecological diseases

Human epididymal protein 4 (HE4) is a novel biomarker and a promising prognostic factor in ovarian cancer patients

Implementation of an enhanced recovery after surgery (ERAS) protocol in a gynaecology department - the follow-up at 1 year

Inhibin A levels in cyst fluid from epithelial ovarian tumors

Leptin levels in serum depending on Body Mass Index in patients with endometrial hyperplasia and cancer

MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer.

New poly(ester-amide) copolymers modified with polyether (PEAE) for anticancer drug encapsulation.

Operative treatment of developmental abnormalities of sexual organs in girls

P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.

Parovarian cysts--not always benign

Premature menopause in patients with BRCA1 gene mutation

Prophylactic salpingo-oophorectomy in BRCA1 mutation carriers and postoperative incidence of peritoneal and breast cancers.

ROMA, an algorithm for ovarian cancer.

Risk Model in Women with Ovarian Cancer Without Mutations

Selected features of breast and peritoneal cancers diagnosed in BRCA1 carriers after risk-reducing salpingo-oophorectomy

Serum HE4, CA125, YKL-40, bcl-2, cathepsin-L and prediction optimal debulking surgery, response to chemotherapy in ovarian cancer.

Serum YKL-40 levels in patients with ovarian cancer and women with BRCA1 gene mutation--comparison to CA 125 antigen

Serum adiponectin in relation to endometrial cancer and endometrial hyperplasia with atypia in obese women

Significance of BRCA1 expression in breast and ovarian cancer patients with brain metastasis - A multicentre study

Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer.

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients

The impact of an expanded genetic testing program and selective oophorectomy on the incidence of ovarian cancer in West Pomerania

The role of lipocalin-2 serum levels in the diagnostics of endometrial cancer

Thrombospondin-I concentrations behavior in plasma of patients with ovarian cancer.

Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

[Adolescent endometriosis]

[Behavior of SCC antigen in girls with a high risk of developing cervical carcinoma]

[Effectiveness of combined treatment in patient with advanced ovarian carcinoma]

[Giant benign ovarian tumor coexisting with late pregnancy--a case report]

[Laparoscopy in the diagnosis and treatment of pathology of sexual organs in girls]

[Surgical treatment in child gynecology. Germ cell tumors of the ovary in girls]

[The comparison of CA-125 and CEA levels in serum and ovarian cyst fluid in girls and young women]

[The levels of selected hormones in serum and ovarian cyst fluid in girls and young women]

sFlt-1/PlGF and Doppler ultrasound parameters in SGA pregnancies with confirmed neonatal birth weight below 10th percentile